Cargando…
HNF1B inhibits cell proliferation via repression of SMAD6 expression in prostate cancer
Prostate cancer is the most common malignancy in men in developed countries. In previous study, we identified HNF1B (Hepatocyte Nuclear Factor 1β) as a downstream effector of Enhancer of zeste homolog 2 (EZH2). HNF1B suppresses EZH2‐mediated migration of two prostate cancer cell lines via represses...
Autores principales: | Lu, Wei, Sun, Jian, Zhou, Huihui, Wang, Fei, Zhao, Chunchun, Li, Kai, Fan, Caibin, Ding, Guanxiong, Wang, Jianqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754016/ https://www.ncbi.nlm.nih.gov/pubmed/33174391 http://dx.doi.org/10.1111/jcmm.16081 |
Ejemplares similares
-
HNF1B-mediated repression of SLUG is suppressed by EZH2 in aggressive prostate cancer
por: Wang, Jianqing, et al.
Publicado: (2019) -
ZBTB38 suppresses prostate cancer cell proliferation and migration via directly promoting DKK1 expression
por: Ding, Guanxiong, et al.
Publicado: (2021) -
Downregulation of PGM5 expression correlates with tumor progression and poor prognosis in human prostate cancer
por: Sun, Jian, et al.
Publicado: (2022) -
Significance of PTEN Mutation in Cellular Process, Prognosis, and Drug Selection in Clear Cell Renal Cell Carcinoma
por: Fan, Caibin, et al.
Publicado: (2019) -
Identification of key pathways and genes in PTEN mutation prostate cancer by bioinformatics analysis
por: Sun, Jian, et al.
Publicado: (2019)